Filing Details

Accession Number:
0001123292-18-000034
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-01-03 19:09:48
Reporting Period:
2018-01-01
Accepted Time:
2018-01-03 19:09:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
881524 Vivus Inc VVUS Pharmaceutical Preparations (2834) 943136179
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1640688 T Santosh Varghese C/O Vivus, Inc.
900 E. Hamilton Ave., Suite 550
Campbell CA 95008
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-01-01 444 $0.51 72,296 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Sold to pay the tax liability resulting from the vesting of 919 restricted stock units granted on January 23, 2015.